[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Mirum Pharmaceuticals, Inc. Common Stock (MIRM)

Mirum Pharmaceuticals is set to acquire Bluejay Therapeutics for up to $XXX million, a move analysts at Baird have raised the price target to $88, citing the potential of Bluejay's brelovitug drug for chronic hepatitis delta virus.

### About Mirum Pharmaceuticals, Inc. Common Stock
Mirum Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing novel therapies for liver diseases.  
Mirum Pharmaceuticals, Inc. Common Stock uses the ticker $MIRM for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Mirum Pharmaceuticals, Inc. Common Stock (MIRM) trading volume is up XXXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/close.tsv)  
The stock is experiencing a bullish trend, hitting a 52-week high, driven by positive analyst recommendations and social media buzz regarding acquisitions and clinical trial progress. However, recent director share sales and a slight price decrease suggest potential short-term caution.  

24-Hour: -XXXX%
7-Day: -XXX%
30-Day: -XXX%

1-Year High: $XXXXX on 2025-09-09  
1-Year Low: $XXXXX on 2025-04-21  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/alt_rank.tsv)  
Mirum Pharmaceuticals, Inc. Common Stock (MIRM) is currently AltRank #1,148 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXXXX +276  
X Month: XXXXX -XX  
1-Year High: XXXXX on 2025-09-26  
1-Year Low: XXX on 2025-08-17  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -X  
1-Year High: XX on 2025-09-20  
1-Year Low: X on 2025-09-16  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX +31%  
X Year: XXXXXXXXX +65%  
1-Year High: XXXXXXX on 2025-02-20  
1-Year Low: XXX on 2025-04-13  

Engagements by network (24h):
News: XXX
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX +7.30%  
X Month: XXX +51%  
X Months: XXXXX +178%  
X Year: XXXXX +73%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-04-13  

Mentions by network (24h):
News: X
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Mirum Pharmaceuticals, Inc. Common Stock (MIRM) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +6.10%  
X Month: XXX +44%  
X Months: XXXXX +301%  
X Year: XXXXX +174%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-04-13  

The most influential creators that mention Mirum Pharmaceuticals, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | X    | XXXXXX    | X     | XXX         |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXX         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XX          |
| [@mirumpharma](/creator/twitter/mirumpharma)         | X    | XXX       | X     | XX          |
| [@James7Dolph](/creator/twitter/James7Dolph)         | X    | XX        | X     | X           |
| [@linhnguyen64143](/creator/twitter/linhnguyen64143) | X    | XX        | X     | X           |

[View More](/list/creators/$mirm/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% +18%  
X Months: XXX% +25%  
X Year: XXX% +29%  
1-Year High: XXX% on 2025-01-19  
1-Year Low: XX% on 2025-03-06  

Most Supportive Themes:
- Positive Analyst Recommendations and Buzz: (70%) Financial analysts and traders are issuing positive recommendations, contributing to significant social media buzz.
- Liver Disease Drug Research: (30%) Discussions highlight the company's focus on developing novel therapies for liver diseases and its potential for growth.
  
Most Critical Themes:
- Stock Performance Concerns: (100%) There are concerns regarding the stock's recent performance and potential associated risks.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXXXX%  
X Week: XXXXXX% +0.0005000000000000004%  
X Month: XXXXX% +0.0052%  
X Months: XXXXX% +0.0063%  
X Year: XXXXX% +0.00010000000000000113%  
1-Year High: XXXX% on 2025-06-29  
1-Year Low: XXXXXX% on 2025-10-24  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXXXX% on 2025-09-08  
1-Year Low: XXXXXXX% on 2025-07-31  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mirm/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mirm/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX -$6.40%  
X Month: $XXXXXXXXXXXXX -$4%  
1-Year High: $XXXXXXXXXXXXX on 2025-09-09  
1-Year Low: $XXXXXXXXXXXXX on 2025-07-31  

### Top Mirum Pharmaceuticals, Inc. Common Stock News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Mirum Therapeutics to buy Bluejay Therapeutics for up to $820M - San Francisco Business Times"  
[News Link](https://www.bizjournals.com/sanfrancisco/news/2025/12/09/mirum-bluejay-merger-novartis.html) [@bizjournals](/creator/x/bizjournals) 2025-12-10T01:05Z 228.6M followers, XXX engagements



### Top Mirum Pharmaceuticals, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"I nibbled some of $MIRM $ARQT $TVTX $LQDA $IMNM and $NAMS. That should get me back to my 50/50 weight of stocks and cash for $XBI $XXX. Now I can sell more stocks at higher price later as the FOMO goes to $130"  
[X Link](https://x.com/Biotech2k1/status/1998414312717836651) [@Biotech2k1](/creator/x/Biotech2k1) 2025-12-09T15:27Z 33.1K followers, 1981 engagements


"Price Target Raises $AR Antero Resources PT $XX from $XX from Morgan Stanley $AR Antero Resources PT $XX from $XX from JPMorgan $ERAS Erasca PT $X from $X from Mizuho $CFLT Confluent PT $XX from $XX from Baird $MIRM Mirum Pharmaceuticals PT $XX from $XX from Baird $PSKY Paramount Skydance PT $XX from $XX from Morgan Stanley $AVGO Broadcom PT $XXX from $XXX from Rosenblatt $NRIX Nurix Therapeutics PT $XX from $XX from BTIG $NEE NextEra Energy PT $XXX from $XX from BTIG $MU Micron PT $XXX from $XXX from Deutsche Bank $KYMR Kymera Therapeutics PT $XXX from $XX from Piper Sandler $WVE Wave Life"  
[X Link](https://x.com/ThePupOfWallSt/status/1998374832388374977) [@ThePupOfWallSt](/creator/x/ThePupOfWallSt) 2025-12-09T12:51Z 48.9K followers, XXX engagements


"Bairdthe PT on $MIRM to $XX from $XX reiterated at Outperform and said Raising target price to $XX on acquisition. $GILD $VIR ARWR JNJ Baird added The agreement to acquire Bluejay Therapeutics for $620M in cash/stock and up to $200M tiered sales milestones brings in a shot on goal at HDV in brelovitug. The drug has already demonstrated a XXX% HDV RNA response in Ph2 and with a Ph3 readout expected 2H26 we think this can be an approvable drug and believe the high unmet need supports the expectation for peak sales to exceed half a billion dollars annually"  
[X Link](https://x.com/Quantumup1/status/1998124188146737295) [@Quantumup1](/creator/x/Quantumup1) 2025-12-08T20:15Z 3919 followers, 1133 engagements


"Mirum Pharmaceuticals Acquisition of Bluejay Therapeutics Strengthens Its Global Rare Disease Leadership #Biotech #Healthcare #Merger #Acquisition #MirumPharmaceuticals #BluejayTherapeutics #RareDiseases #Investing #Channelchek"  
[X Link](https://x.com/channelchek/status/1998116293002527128) [@channelchek](/creator/x/channelchek) 2025-12-08T19:43Z 1461 followers, XX engagements